Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,418
Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
for
Advanced Osteosarcoma, Recurrent Osteosarcoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 1 - 70+
Code: NCT07227571
Phase1, Recruiting
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Location: Seattle WA, Salt Lake City UT, Dallas TX, Chicago IL,
Sponsor: Debiopharm International SA
Sex: All
Age: 18+
Code: NCT05765812
Phase1, Phase2, Recruiting
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
for
Locally Advanced Malignant Solid Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT04515810
Recruiting
IVIG for Infection Prevention After CAR-T-Cell Therapy
for
Hematologic Malignancies
Location: Seattle WA, Portland OR, Duarte CA, New York NY,
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT05952804
Phase2, Recruiting
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT05098210
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors, HNSCC, SCLC, NSCLC,
Location: Seattle WA, Rochester MN, Irving TX, St Louis MO,
Sponsor: Tubulis GmbH
Sex: All
Age: 18+
Code: NCT06657222
Phase1, Phase2, Recruiting
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
for
Leukemia, Myeloid, Chronic, Myeloid Leukemia,
Location: Seattle WA, Duarte CA, Houston TX, Cleveland OH,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT04260022
Phase1, Recruiting
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
for
Prostate Cancer
Location: Seattle WA, Vancouver, Sacramento CA, Ann Arbor MI,
Sponsor: University of British Columbia
Sex: Male
Age: 18+
Code: NCT04812366
Phase2, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Seattle WA, Portland OR, Calgary, San Francisco CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase2, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Seattle WA, Portland OR, Duarte CA, Los Angeles CA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Location: Seattle WA, Salt Lake City UT, Los Angeles CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06445062
Phase1, Phase2, Recruiting
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
MYELODYSPLASTIC SYNDROME; MDS, ACUTE MYELOID LEUKEMIA; AML
Location: Seattle WA, Portland OR, Salt Lake City UT, Stanford CA,
Sponsor: Jasper Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04429191
Phase1, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Seattle WA, Vancouver, San Francisco CA, Glendale CA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms